4-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate

Michael A. Letavic, Anindya Bhattacharya, Brett D. Allison et al.|Journal of Medicinal Chemistry|2017

Cited by 69